RxDoctor Payments Data

Deborah Krause, DO

Psychiatry · Jefferson City, MONPI 1962568550

Payments from drug & device makers

$2,412in general payments, 2019–2025

Across 167 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Lundbeck LLC$315
  • Otsuka America Pharmaceutical, Inc.$308
  • Neurocrine Biosciences, Inc.$295
  • Johnson & Johnson$212
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$180
  • plus $760 from 14 others

What the payments were for

  • Food & beverage$2,35398%
  • Education$582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,412 in reported general payments places this provider in the 75th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$42,062
Medicare patients
135
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl51$84,426
RexultiBrexpiprazole41$57,124
EmsamSelegiline11$22,070
TrintellixVortioxetine Hydrobromide23$10,589
Lisdexamfetamine Dimesylate30$7,907
VyvanseLisdexamfetamine Dimesylate20$7,450
Vilazodone Hcl63$7,347
Aripiprazole150$6,977
Clozapine59$6,924
Lurasidone Hcl56$6,636
Venlafaxine Hcl ErVenlafaxine Hcl276$4,775
Paliperidone ErPaliperidone13$4,588
Quetiapine Fumarate219$4,403
Desvenlafaxine Succinate ErDesvenlafaxine Succinate80$4,258
Duloxetine Hcl125$3,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$342$84,42651 claims
Otsuka America Pharmaceutical, Inc.Rexulti$308$57,12441 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$146$18,03943 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →